N
NavonTech
Developed GlycemiaCare, a noninvasive wearable for identifying nocturnal hypoglycemia in diabetics.
About
NavonTech developed GlycemiaCare, a noninvasive wearable technology designed to identify nocturnal hypoglycemia. This condition, a drop in blood glucose levels, is a complication associated with insulin treatment for diabetes. The company aimed to provide a solution for diabetics experiencing these events.
Technology stack
detected 2026-05-24Est. monthly stack spend~$20/mo
Emailnone
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does NavonTech do?
NavonTech developed GlycemiaCare, a noninvasive wearable technology designed to identify nocturnal hypoglycemia. This condition, a drop in blood glucose levels, is a complication associated with insulin treatment for diabetes. The company aimed to provide a solution for diabetics experiencing these events.
When was NavonTech founded?
NavonTech was founded in 2017.
What industry does NavonTech operate in?
NavonTech operates in Healthcare, Monitor, Diabetes, HealthTech, MedTech, Wearables.
How many employees does NavonTech have?
NavonTech has approximately 3 people on record.
What is NavonTech's current status?
NavonTech's current operating status is: Inactive.